Did Bivianta let Rip buy it?

Yes Biviaantai is an enterprise mainly engaged in technology promotion and application service industry, which has been acquired by Rip. Based on high-end genetic engineering, cell engineering, fermentation engineering and other technologies, Ruipu Biological Products Industry develops and produces biomedical products for the prevention, treatment and diagnosis of diseases of poultry, livestock, cows and pets, including inactivated vaccines, live vaccines, diagnostic reagents (boxes), genetically engineered vaccines, synthetic skin vaccines and antibodies for animals.